Vinayak Doraiswamy, Chief Scientific Officer at AtriCure, Inc. (ATRC), sold 2,500 shares at $33.44 ($84K) on 2025-05-28, disclosed to the SEC on 2025-05-30.
Open-market sale of $84k ATRC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2026-03-16 | $149K | — | Filing → |
| ATRC | SELL | 2025-08-07 | $91K | — | Filing → |
| ATRC | SELL | 2022-09-19 | $458K | — | Filing → |